Importance of cognitive disorders in internal medicine: Pathophysiology, diagnosis, management. The example of systemic lupus erythematosus

被引:1
作者
Peter, E. [1 ]
Robert, M. [2 ]
Guinet, V [3 ]
Krolak-Salmon, P. [4 ]
Desestret, V [4 ,5 ]
Jacquin-Courtois, S. [6 ]
Cohen, F. [7 ]
Seve, P. [1 ]
Garnier-Crussard, A. [4 ]
机构
[1] Univ Lyon, Hosp Civils Lyon, Serv Med Interne, Hop Croix Rousse, Lyon, France
[2] Univ Lyon, Hosp Civils Lyon, Serv Med Interne & Immunol Clin, Hop Edouard Herriot, Lyon, France
[3] Hosp Civils Lyon, Serv Neurol Fonct & Epileptol, Hop Pierre Wertheimer, Lyon, France
[4] Hosp Civils Lyon, Ctr Memoire Ressource & Rech Lyon CMRR, Inst Vieillissement Vie 1, Hop Charpennes, Lyon, France
[5] Hosp Civils Lyon, Serv Neurocognit & Neuroophtalmol, Hop Pierre Wertheimer, Lyon, France
[6] Hosp Civils Lyon, Serv Med Phys & Readaptat, Hop Henry Gabrielle, Reeduc Neurol, F-69230 St Genis Laval, France
[7] Sorbonne Univ, Grp Hosp Pitie Salpetriere, AP HP, Serv Med Interne 2,Inst E3M, Paris, France
来源
REVUE DE MEDECINE INTERNE | 2022年 / 43卷 / 01期
关键词
Cognitive dysfunction; Neuropsychiatric manifestations; Systemic diseases; Systemic lupus erythematosus; BRIEF SCREENING TOOL; NEUROPSYCHIATRIC LUPUS; BRAIN-FUNCTION; T-CELLS; IMPAIRMENT; DEPRESSION; DYSFUNCTION; VALIDITY; DEMENTIA; ANXIETY;
D O I
10.1016/j.revmed.2021.08.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic diseases, which are in France mainly monitored in internal medicine, affect multiple organs or tissues. While cutaneous or articular manifestations are the most common, neurological involvement is often associated with severity. Diagnosis of peripheral (e.g, neuropathies) or central (e.g, myelitis) nervous disorders is quite easy through clinical examination and dedicated complementary tests. However, neuropsychological manifestations that affect cognition, including memory, attention, executive functions or reasoning, are difficult to diagnose, sometimes trivialized by practitioners. Their causes are often numerous and interrelated. Nevertheless, these cognitive manifestations are closely related to patients' quality of life, affecting their social life, family dynamics and professional integration but also the treatment adherence. The purpose of this review, focused on the example of systemic lupus erythematosus, is to raise awareness of cognitive dysfunction in systemic diseases including their management from diagnosis to treatments. The final aim is to go further into setting up research groups and care programs for patients with cognitive impairment followed in internal medicine. (C) 2021 Societe Nationale Francaise de Medecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 88 条
[1]   Cognitive Functioning in the First-Episode of Major Depressive Disorder: A Systematic Review and Meta-Analysis [J].
Ahern, Elayne ;
Semkovska, Maria .
NEUROPSYCHOLOGY, 2017, 31 (01) :52-72
[2]   What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis [J].
Al Rayes, Hanan ;
Tani, Chiara ;
Kwan, Andrew ;
Marzouk, Sherief ;
Colosimo, Kenneth ;
Medina-Rosas, Jorge ;
Mustafa, Ahmed ;
Su, Jiandong ;
Lambiris, Panos ;
Mosca, Marta ;
Touma, Zahi .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 48 (02) :240-255
[3]   Prevalence of Mood and Anxiety Disorders in Women With Systemic Lupus Erythematosus [J].
Bachen, Elizabeth A. ;
Chesney, Margaret A. ;
Criswell, Lindsey A. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (06) :822-829
[4]   Depression and pain comorbidity - A literature review [J].
Bair, MJ ;
Robinson, RL ;
Katon, W ;
Kroenke, K .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (20) :2433-2445
[5]   Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus [J].
Barile-Fabris, L ;
Ariza-Andraca, R ;
Olguín-Ortega, L ;
Jara, LJ ;
Fraga-Mouret, A ;
Miranda-Limón, JM ;
de la Mata, JF ;
Clark, P ;
Vargas, F ;
Alcocer-Varela, J .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (04) :620-625
[6]   Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changes [J].
Barraclough, Michelle ;
Mckie, Shane ;
Parker, Ben ;
Jackson, Alan ;
Pemberton, Philip ;
Elliott, Rebecca ;
Bruce, Ian N. .
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (07) :934-940
[7]   CNS-specific T cells shape brain function via the choroid plexus [J].
Baruch, Kuti ;
Schwartz, Michal .
BRAIN BEHAVIOR AND IMMUNITY, 2013, 34 :11-16
[8]   Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis [J].
Benedict, Ralph H. B. ;
DeLuca, John ;
Phillips, Glenn ;
LaRocca, Nicholas ;
Hudson, Lynn D. ;
Rudick, Richard .
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (05) :721-733
[9]   Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis [J].
Berende, Anneleen ;
ter Hofstede, Hadewych J. M. ;
Vos, Fidel J. ;
Vogelaar, Michiel L. ;
van Middendorp, Henriet ;
Evers, Andrea W. M. ;
Kessels, Roy P. C. ;
Kullberg, Bart Jan .
NEUROLOGY, 2019, 92 (13) :E1447-E1455
[10]   EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs [J].
Bertsias, G. K. ;
Ioannidis, J. P. A. ;
Aringer, M. ;
Bollen, E. ;
Bombardieri, S. ;
Bruce, I. N. ;
Cervera, R. ;
Dalakas, M. ;
Doria, A. ;
Hanly, J. G. ;
Huizinga, T. W. J. ;
Isenberg, D. ;
Kallenberg, C. ;
Piette, J. C. ;
Schneider, M. ;
Scolding, N. ;
Smolen, J. ;
Stara, A. ;
Tassiulas, I. ;
Tektonidou, M. ;
Tincani, A. ;
van Buchem, M. A. ;
van Vollenhoven, R. ;
Ward, M. ;
Gordon, C. ;
Boumpas, D. T. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (12) :2074-2082